• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者的多种药物治疗、药物相关问题和潜在不适当药物的影响及其对保加利亚的意义——叙述性综述和荟萃分析。

Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis.

机构信息

Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.

出版信息

Front Public Health. 2022 Mar 3;10:743138. doi: 10.3389/fpubh.2022.743138. eCollection 2022.

DOI:10.3389/fpubh.2022.743138
PMID:35309221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8927684/
Abstract

OBJECTIVE

Polypharmacy and inappropriate prescribing are overlooked issues in Bulgaria. We aimed at collecting and analyzing global literature on the most prevalent risk factors and investigating what they could reveal about current practice.

MATERIALS AND METHODS

A systematic narrative review and meta-analysis was conducted on the topic, investigating the prevalence of polypharmacy, odds of potentially inappropriate medications (PIMs) due to polypharmacy, and the likelihood of developing a drug-related problem (DRP) due to PIMs. The results were then related to current demographic statistics to estimate the potential impact on Bulgarian elderly patients.

RESULTS

The prevalence of polypharmacy was estimated at 41% in elderly populations. The odds of a potentially inappropriate medication being prescribed were 2.095, with an expected 30.84% of those leading to a DRP. These numbers indicated that the expected Bulgarian elderly with polypharmacy should be 709,676 with 212,903 cases of DRPs.

CONCLUSION

Global polypharmacy rates seem to be on the rise, with an expected increase in DRPs.

摘要

目的

药物滥用和不适当处方是保加利亚被忽视的问题。我们旨在收集和分析全球关于最常见风险因素的文献,并研究这些因素能反映出当前的实践情况。

材料和方法

对该主题进行了系统的叙述性综述和荟萃分析,调查了药物滥用的普遍性、因药物滥用而导致的潜在不适当药物的可能性以及因潜在不适当药物而导致药物相关问题的可能性。然后,将结果与当前的人口统计学统计数据相关联,以估计对保加利亚老年患者的潜在影响。

结果

老年人中药物滥用的患病率估计为 41%。开出潜在不适当药物的可能性为 2.095,预计其中 30.84%会导致药物相关问题。这些数字表明,预期有 709676 名保加利亚老年患者存在药物滥用,其中 212903 例会出现药物相关问题。

结论

全球药物滥用率似乎呈上升趋势,预计药物相关问题也会增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/c06310c4dca2/fpubh-10-743138-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/b2c8004f3a4f/fpubh-10-743138-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/90f5d72976ed/fpubh-10-743138-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/b66de80edd7b/fpubh-10-743138-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/07518e234c7d/fpubh-10-743138-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/c06310c4dca2/fpubh-10-743138-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/b2c8004f3a4f/fpubh-10-743138-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/90f5d72976ed/fpubh-10-743138-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/b66de80edd7b/fpubh-10-743138-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/07518e234c7d/fpubh-10-743138-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f0/8927684/c06310c4dca2/fpubh-10-743138-g0005.jpg

相似文献

1
Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis.老年患者的多种药物治疗、药物相关问题和潜在不适当药物的影响及其对保加利亚的意义——叙述性综述和荟萃分析。
Front Public Health. 2022 Mar 3;10:743138. doi: 10.3389/fpubh.2022.743138. eCollection 2022.
2
Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis.发展中国家老年人群多重用药的患病率及潜在不适当用药风险:一项系统评价与荟萃分析
Gerontology. 2022;68(2):136-145. doi: 10.1159/000516075. Epub 2021 May 11.
3
Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).老年患者的药物使用与年龄盲视方法:叙述性文献综述(关于老年人药物疗效和安全性的证据不足、不适当药物频繁使用和多重用药以及有益非药物策略使用不足)
Eur J Clin Pharmacol. 2019 Apr;75(4):451-466. doi: 10.1007/s00228-018-2603-5. Epub 2019 Jan 4.
4
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.老年癌症患者中的严重药物相互作用及潜在不适当用药情况。
Support Care Cancer. 2017 Jan;25(1):229-236. doi: 10.1007/s00520-016-3409-6. Epub 2016 Sep 12.
5
Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.在肿瘤门诊化疗环境下,老年癌症患者接受化疗的药物使用频度和药物使用风险。
Curr Oncol Rep. 2018 Mar 26;20(5):38. doi: 10.1007/s11912-018-0686-x.
6
A prevalence study of potentially inappropriate medications use in hospitalized Pakistani elderly.一项针对巴基斯坦住院老年患者潜在不适当药物使用的流行性病学研究。
Aging Clin Exp Res. 2018 Jan;30(1):53-60. doi: 10.1007/s40520-017-0742-7. Epub 2017 Mar 3.
7
Potentially inappropriate medications with polypharmacy increase the risk of falls in older Japanese patients: 1-year prospective cohort study.多药治疗伴随潜在不适当药物会增加日本老年患者跌倒风险:一项为期 1 年的前瞻性队列研究。
Geriatr Gerontol Int. 2018 Jul;18(7):1064-1070. doi: 10.1111/ggi.13307. Epub 2018 Mar 26.
8
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.多药治疗、不适当药物使用和药物相互作用在接受一线姑息化疗的老年韩国癌症患者中的情况。
Oncologist. 2020 Mar;25(3):e502-e511. doi: 10.1634/theoncologist.2019-0085. Epub 2019 Nov 27.
9
Using two tools to identify Potentially Inappropriate Medications (PIM) in elderly patients in Southern Chile.使用两种工具识别智利南部老年患者中的潜在不适当用药(PIM)。
Arch Gerontol Geriatr. 2016 Nov-Dec;67:139-44. doi: 10.1016/j.archger.2016.08.001. Epub 2016 Aug 3.
10
Costs of medication in older patients: before and after comprehensive geriatric assessment.老年患者药物治疗费用:全面老年评估前后。
Clin Interv Aging. 2018 Apr 9;13:607-613. doi: 10.2147/CIA.S159966. eCollection 2018.

引用本文的文献

1
Prevalence and factors with potentially inappropriate prescribing among older outpatients with depression: a multicentre study across China.老年抑郁症门诊患者中潜在不适当处方的患病率及相关因素:一项中国多中心研究
J Glob Health. 2025 Jul 11;15:04216. doi: 10.7189/jogh.15.04216.
2
Potentially Inappropriate Medication Use Among Older Adults with Cognitive Impairment and Dementia Attending Primary Care-Based Memory Clinics.在参加基层医疗记忆诊所的认知障碍和痴呆症老年患者中潜在不适当用药情况
Pharmacy (Basel). 2025 Jun 7;13(3):82. doi: 10.3390/pharmacy13030082.
3
Analysis of the level of polypharmacy in patients from an isolated rural area: effect of age, sex, and chronic diseases.

本文引用的文献

1
A pharmacist's unique opportunity within a multidisciplinary team to reduce drug-related problems for older adults in an intermediate care setting.药剂师在多学科团队中为老年患者在中级护理环境中减少药物相关问题的独特机会。
Res Social Adm Pharm. 2022 Apr;18(4):2625-2633. doi: 10.1016/j.sapharm.2021.05.003. Epub 2021 May 6.
2
Medication-related problems in older people in Catalonia: A real-world data study.加泰罗尼亚老年人的药物相关问题:真实世界数据研究。
Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):220-228. doi: 10.1002/pds.5149. Epub 2020 Nov 26.
3
Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey.
偏远农村地区患者多重用药水平分析:年龄、性别及慢性病的影响
Front Digit Health. 2025 Jun 10;7:1508505. doi: 10.3389/fdgth.2025.1508505. eCollection 2025.
4
Trends of potentially inappropriate prescribing among older outpatients in China between 2015-21.2015年至2021年中国老年门诊患者潜在不适当处方的趋势。
J Glob Health. 2025 Jun 20;15:04190. doi: 10.7189/jogh.15.04190.
5
Polypharmacy, drug-drug interactions and adverse drug reactions in older Chinese cancer patients: evidence from CHARLS.中国老年癌症患者的多重用药、药物相互作用及药物不良反应:来自中国健康与养老追踪调查(CHARLS)的证据
Front Pharmacol. 2025 May 29;16:1579023. doi: 10.3389/fphar.2025.1579023. eCollection 2025.
6
Prevalence and Factors with Potentially Inappropriate Prescribing among Older Surgical Outpatients in China: A Nationwide Cross-sectional Study in 100 Hospitals.中国老年外科门诊患者中潜在不适当处方的患病率及相关因素:一项在100家医院开展的全国性横断面研究
J Epidemiol Glob Health. 2025 Mar 12;15(1):39. doi: 10.1007/s44197-025-00378-x.
7
Impact of Chinese criteria on potentially inappropriate medication use in China.中国标准对中国潜在不适当用药的影响。
J Glob Health. 2025 Feb 7;15:04063. doi: 10.7189/jogh.15.04063.
8
Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal.尼泊尔西部孙瓦尔市 2 型糖尿病患者的药物相关问题。
PLoS One. 2024 Nov 21;19(11):e0309781. doi: 10.1371/journal.pone.0309781. eCollection 2024.
9
Adverse drug reactions and drug-related problems with supportive care medications among the oncological population.肿瘤患者中支持性护理药物的药物不良反应及药物相关问题
Discov Oncol. 2024 Sep 9;15(1):416. doi: 10.1007/s12672-024-01300-w.
10
Food Supplements and Their Use in Elderly Subjects-Challenges and Risks in Selected Health Issues: A Narrative Review.食品补充剂及其在老年人群中的应用——特定健康问题中的挑战与风险:一篇叙述性综述
Foods. 2024 Aug 21;13(16):2618. doi: 10.3390/foods13162618.
多病症和多种药物治疗对心房颤动患者管理的影响:巴尔干房颤调查的见解。
Ann Med. 2021 Dec;53(1):17-25. doi: 10.1080/07853890.2020.1799241. Epub 2020 Aug 4.
4
Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review.定义老年癌症患者的治疗不足和过度治疗:文献范围综述。
J Clin Oncol. 2020 Aug 1;38(22):2558-2569. doi: 10.1200/JCO.19.02809. Epub 2020 Apr 6.
5
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.老年人潜在不适当药物/潜在处方遗漏的 STOPP/START 标准:起源和进展。
Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30.
6
The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients.临床药师在预防老年心力衰竭患者潜在药物相互作用中的作用。
Int J Clin Pharm. 2019 Dec;41(6):1555-1561. doi: 10.1007/s11096-019-00918-z. Epub 2019 Oct 8.
7
Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).聚焦于个人目标、生活质量和多重用药老年人健康问题的临床药物治疗评估对其影响:一项随机对照试验(DREAMeR 研究)。
PLoS Med. 2019 May 8;16(5):e1002798. doi: 10.1371/journal.pmed.1002798. eCollection 2019 May.
8
Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.医疗保险受益人与慢性病、多种药物治疗和药物相关问题之间的关联。
J Manag Care Spec Pharm. 2019 May;25(5):573-577. doi: 10.18553/jmcp.2019.25.5.573.
9
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.美国老年医学学会 2019 年更新的老年人潜在不适当药物使用 AGS Beers 标准®。
J Am Geriatr Soc. 2019 Apr;67(4):674-694. doi: 10.1111/jgs.15767. Epub 2019 Jan 29.
10
What is polypharmacy? A systematic review of definitions.什么是多重用药?定义的系统综述。
BMC Geriatr. 2017 Oct 10;17(1):230. doi: 10.1186/s12877-017-0621-2.